CDC logo, Safer Healthier People  CDC HomeCDC SearchCDC Health Topics A-Z
NIOSH - National Institute for Occupational Safety and Health

Search NIOSH  |  NIOSH Home  |  NIOSH Topics  |  Site Index  |  Databases and Information Resources  |  NIOSH Products  |  Contact Us






Propanedial

RTECS #: TX6475000

CAS #: 542-78-9


UPDATE: May 2009 MW: 72.07 MF: C3H4O2


NOTE:

TABLE OF CONTENTS:
  1. SYNONYMS:
  2. MUTATION DATA:
  3. TUMORIGENIC DATA:
  4. ACUTE TOXICITY DATA:
  5. OTHER MULTIPLE DOSE DATA:
  6. REVIEWS:
  7. NIOSH DOCUMENTATION AND SURVEILLANCE:
  8. STATUS IN FEDERAL AGENCIES:
  9. REFERENCES:

SYNONYMS:

  1. 1,3 - Propanedial
  2. 1,3 - Propanedialdehyde
  3. 1,3 - Propanedione
  4. Malonaldehyde
  5. Malondialdehyde
  1. Malonic aldehyde
  2. Malonic dialdehyde
  3. Malonodialdehyde
  4. Malonyldialdehyde
  5. NCI - C54842


SKIN AND EYE IRRITATION DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


MUTATION DATA AND REFERENCES:

SYSTEM TEST ROUTE/
ORGANISM/
TISSUE
DOSE REFERENCE
DNA adduct Escherichia coli 20 mmol/L MUREAV 88,23,1981
DNA adduct mammal (species unspecified) lymphocyte 250 mg/L/5 hour EJBCAI 5,178,1968
DNA adduct intraperitoneal
mouse
3,000 nmol/L/1 week- intermittent CALEDQ 185,13,2002
DNA damage human leukocyte 1 mmol/L CLREAS 23(5),595A,1975
DNA damage human fibroblast 10 Ámol/L CLREAS 23(5),595A,1975
DNA inhibition human fibroblast 25 mg/L EJBCAI 5,178,1968
DNA inhibition rat fibroblast 1 mmol/L JTEHD6 6,811,1980
DNA repair Escherichia coli 20 mmol/L MUREAV 88,23,1981
mutation in microorganisms Escherichia coli 2 mmol/L (-enzymatic activation step) MUREAV 88,23,1981
mutation in microorganisms Salmonella typhimurium 13,850 nmol/plate (+enzymatic activation step) BTERDG 2,81,1980
mutation in microorganisms Salmonella typhimurium 1 nmol/plate (-enzymatic activation step) MUREAV 78,113,1980
mutation in mammalian somatic cells mouse lymphocyte 10 Ámol/L MAGDA3 11,137,1979
morphological transform rat fibroblast 1 mmol/L JTEHD6 6,811,1980
other mutation test systems rat fibroblast 100 Ámol/L JTEHD6 6,811,1980


REPRODUCTIVE EFFECTS DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
N/R
N/R N/R N/R


TUMORIGENIC DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
skin
mouse
lowest published toxic dose: 7,488 mg/kg/2 year- intermittent Tumorigenic: Carcinogenic by RTECS criteria

Lung, Thorax, or Respiration: Tumors

Blood: Lymphoma including Hodgkin's disease
AUODDK 55,3,1980
skin
mouse
toxic dose : 30 gm/kg/9 week- intermittent Tumorigenic: Carcinogenic by RTECS criteria

Skin and Appendages: Tumors

Tumorigenic: Tumors at site of application
JNCIAM 53,1771,1974


ACUTE TOXICITY DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
oral
mouse
lethal dose (50 percent kill): 606 mg/kg N/R AUODDK 55,3,1980
oral
rat
lethal dose (50 percent kill): 632 mg/kg Behavioral: Muscle weakness

Lung, Thorax, or Respiration: Dyspnea

Lung, Thorax, or Respiration: Cyanosis
TXAPA9 7,826,1965


OTHER MULTIPLE DOSE DATA AND REFERENCES:

ROUTE/
ORGANISM
DOSE
EFFECT

REFERENCE
oral
mouse
lowest published toxic dose: 45,000 mg/kg/90 day- continuous Nutritional and Gross Metabolic: Weight loss or decreased weight gain VCVGK* -,403,1994
oral
mouse
lowest published toxic dose: 22,500 mg/kg/90 day- continuous Gastrointestinal: Other changes

Liver: Other changes

Kidney, Ureter, and Bladder: Inflammation, necrosis or scarring of bladder
VCVGK* -,403,1994
oral
rat
lowest published toxic dose: 36.5 mg/kg/1 year- continuous Liver: Tumors

Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field
VCVGK* -,403,1994


REVIEWS:

ORGANIZATION STANDARD
REFERENCE

International Agency for Research on Cancer (IARC) Cancer Review Animal Limited Evidence IMEMDT 71,1037,1999
International Agency for Research on Cancer (IARC) Cancer Review Animal Inadequate Evidence IMEMDT 36,163,1985
International Agency for Research on Cancer (IARC) Cancer Review Human No Adequate Data IMEMDT 36,163,1985
International Agency for Research on Cancer (IARC) Cancer Review Human No Adequate Data IMEMDT 71,1037,1999
International Agency for Research on Cancer (IARC) Cancer Review Group 3 IMEMDT 71,1037,1999
TOXICOLOGY REVIEW
TOLED5 134,51,2002
TOXICOLOGY REVIEW
MUREAV 544,115,2003
TOXICOLOGY REVIEW
MUREAV 531,1,2003
TOXICOLOGY REVIEW
MUREAV 531,219,2003
TOXICOLOGY REVIEW
MUTAEX 19,169,2004
TOXICOLOGY REVIEW
MUREAV 659,56,2008
TOXICOLOGY REVIEW
MUREAV 659,68,2008
TOXICOLOGY REVIEW
MUREAV 659,15,2008
TOXICOLOGY REVIEW
MUREAV 574,92,2005
TOXICOLOGY REVIEW
MUREAV 681,93,2009


STANDARDS AND REGULATIONS:

ORGANIZATION STANDARD
REFERENCE

N/R N/R N/R


NIOSH DOCUMENTATION AND SURVEILLANCE:

ORGANIZATION STANDARD or SURVEY
REFERENCE

National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO MALONALDEHYDE-air Carcinogen lowest feasible concentration NIOSH* DHHS #92-100,1992


STATUS IN FEDERAL AGENCIES:

ORGANIZATION
REFERENCE

EPA GENETOX PROGRAM 1988, Inconclusive: Histidine reversion-Ames test
Used as a food and feed additive, flavor and packaging material
NIOSH CURRENT INTELLIGENCE BULLETIN #55, September 1991


REFERENCES:

CODEN
REFERENCE

AUODDK Acta Universitatis Ouluensis, Series D: Medica. (Oulu Univ. Library, Box 186, SF-90101 Oulu 10, Finland) No.1- 1972-
BTERDG Biological Trace Element Research. (Humana Press Inc., POB 2148, Clifton, NJ 07015) V.1- 1979-
CALEDQ Cancer Letters (Shannon, Ireland). (Elsevier Scientific Pub. Ireland Ltd., POB 85, Limerick, Ireland) V.1- 1975-
CLREAS Clinical Research. (Slack Inc., 6900 Grove Rd., Thorofare, NJ 08086) V.6- 1958-
EJBCAI European Journal of Biochemistry. (Springer-Verlag New York, Inc., Service Center, 44 Hartz Way, Secaucus, NJ 07094) V.1- 1967-
IMEMDT IARC Monographs on the Evaluation of Carcinogenic Risk of Chemicals to Man. (WHO Publications Centre USA, 49 Sheridan Ave., Albany, NY 12210) V.1- 1972-
JNCIAM Journal of the National Cancer Institute. (Washington, DC) V.1-60, 1940-78. For publisher information, see JJIND8.
JTEHD6 Journal of Toxicology and Environmental Health. (Hemisphere Pub., 1025 Vermont Ave., NW, Washington, DC 20005) V.1- 1975/76-
MAGDA3 Mechanisms of Ageing and Development. (Elsevier Science Pub. Co., Inc., 52 Vanderbilt Ave., New York, NY 10017) V.1- 1972-
MUREAV Mutation Research. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1964-
MUTAEX Mutagenesis. (Oxford Univ. Press, Pinkhill House, Southfield Road, Eynsham, Oxford OX8 1JJ, UK) V.1- 1986-
NIOSH* National Institute of Occupational Safety and Health, U.S. Dept. of Health, Education, and Welfare, Reports and Memoranda.
TOLED5 Toxicology Letters. (Elsevier Science Pub. B.V., POB 211, 1000 AE Amsterdam, Netherlands) V.1- 1977-
TXAPA9 Toxicology and Applied Pharmacology. (Academic Press, Inc., 1 E. First St., Duluth, MN 55802) V.1- 1959-
VCVGK* "Vrednie chemichescie veshestva, galogen I kislorod sodergashie organicheskie soedinenia". (Hazardous substances. Galogen and oxygen containing substances), Bandman A.L. et al., Chimia, 1994.

Used as a food and feed additive, flavor and packaging material

RTECS Compound Description:
   Tumorigen
   Mutagen
   Human Data

Click Here for Additional Information about RTECS

NIOSH Home |  NIOSH Search  |  Site Index  |  Topic List |  Contact Us